Free GAQM ISO-QMS-13485 Exam Questions
Absolute Free ISO-QMS-13485 Exam Practice for Comprehensive Preparation
-
GAQM ISO-QMS-13485 Exam Questions
-
Provided By: GAQM
- Exam: ISO 13485:2016 - Certified Lead Auditor
- Certification: GAQM ISO
-
Total Questions: 300
-
Updated On: May 21, 2026
-
Rated: 4.9 |
-
Online Users: 600
-
Question 1
-
A medical device company manufactures Class IIa devices and is undergoing an ISO 13485:2016 audit. During a review of the organization's change control process, the Lead Auditor discovers that the company's impact assessment for product changes only focuses on assessing the impact to the design and manufacturing processes. There is no documented procedure for assessing the impact of the change on device labeling, including IFU (Instructions for Use), warnings and precautions, symbols, or any regulatory labeling requirements. As the Lead Auditor, what is the MOST appropriate action to take?
Answer: D
-
A medical device company manufactures Class IIa devices and is undergoing an ISO 13485:2016 audit. During a review of the organization's change control process, the Lead Auditor discovers that the company's impact assessment for product changes only focuses on assessing the impact to the design and manufacturing processes. There is no documented procedure for assessing the impact of the change on device labeling, including IFU (Instructions for Use), warnings and precautions, symbols, or any regulatory labeling requirements. As the Lead Auditor, what is the MOST appropriate action to take?
-
Question 2
-
A medical device company uses a contract manufacturer to produce a critical component for one of their Class III devices. During an ISO 13485:2016 audit of the medical device company (not the contract manufacturer), the Lead Auditor reviews the records pertaining to the oversight of the contract manufacturer. The records show regular communication, agreed-upon specifications, and documented inspections of incoming components. However, there is no documented evidence of periodic on-site audits of the contract manufacturer's facilities. What is the MOST appropriate conclusion for the Lead Auditor to draw?
Answer: C
-
A medical device company uses a contract manufacturer to produce a critical component for one of their Class III devices. During an ISO 13485:2016 audit of the medical device company (not the contract manufacturer), the Lead Auditor reviews the records pertaining to the oversight of the contract manufacturer. The records show regular communication, agreed-upon specifications, and documented inspections of incoming components. However, there is no documented evidence of periodic on-site audits of the contract manufacturer's facilities. What is the MOST appropriate conclusion for the Lead Auditor to draw?
-
Question 3
-
A medical device company is undergoing an ISO 13485:2016 audit. The company manufactures a Class IIa medical device. The Lead Auditor discovers that the company's internal audit program is conducted by personnel who have received training on auditing techniques but lack specific technical expertise related to the processes they are auditing (e.g., design, manufacturing, sterilization). The company claims that the auditors' general understanding of the QMS is sufficient. What is the MOST appropriate action for the Lead Auditor to take?
Answer: C
-
A medical device company is undergoing an ISO 13485:2016 audit. The company manufactures a Class IIa medical device. The Lead Auditor discovers that the company's internal audit program is conducted by personnel who have received training on auditing techniques but lack specific technical expertise related to the processes they are auditing (e.g., design, manufacturing, sterilization). The company claims that the auditors' general understanding of the QMS is sufficient. What is the MOST appropriate action for the Lead Auditor to take?
-
Question 4
-
A medical device company is undergoing an ISO 13485:2016 audit. The company outsources the manufacturing of a critical component to a supplier. During the audit, the Lead Auditor discovers the supplier performs 100% automated inspection of the critical dimensions of the component, and the medical device company's quality group does not perform incoming inspection. The Lead Auditor reviews the process for controlling these outsourced processes and confirms the supplier's automated inspection system used to verify critical product dimensions is validated. What additional action must be verified by the Lead Auditor to ensure compliance?
Answer: B
-
A medical device company is undergoing an ISO 13485:2016 audit. The company outsources the manufacturing of a critical component to a supplier. During the audit, the Lead Auditor discovers the supplier performs 100% automated inspection of the critical dimensions of the component, and the medical device company's quality group does not perform incoming inspection. The Lead Auditor reviews the process for controlling these outsourced processes and confirms the supplier's automated inspection system used to verify critical product dimensions is validated. What additional action must be verified by the Lead Auditor to ensure compliance?
-
Question 5
-
A medical device company is undergoing an ISO 13485:2016 audit. The company utilizes a contract manufacturer for a critical component of their Class II medical device. The Lead Auditor reviews the company's process for controlling the outsourced process. The quality agreement with the contract manufacturer clearly defines the product specifications, quality requirements, and acceptance criteria. There is evidence of recent performance data trending showing sustained compliance, however, the quality agreement does not define how frequently the quality agreement itself is reviewed or updated. As a Lead Auditor, what is the MOST appropriate determination regarding the company's approach?
Answer: B
-
A medical device company is undergoing an ISO 13485:2016 audit. The company utilizes a contract manufacturer for a critical component of their Class II medical device. The Lead Auditor reviews the company's process for controlling the outsourced process. The quality agreement with the contract manufacturer clearly defines the product specifications, quality requirements, and acceptance criteria. There is evidence of recent performance data trending showing sustained compliance, however, the quality agreement does not define how frequently the quality agreement itself is reviewed or updated. As a Lead Auditor, what is the MOST appropriate determination regarding the company's approach?